Pre-treatment considerations in childhood hypertension due to chronic kidney disease.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4635370)

Published in World J Nephrol on November 06, 2015

Authors

Wasiu Adekunle Olowu1

Author Affiliations

1: Wasiu Adekunle Olowu, Paediatric Nephrology and Hypertension Unit, Obafemi Awolowo University Teaching Hospitals Complex, PMB 5538, Ile-Ife, State of Osun, Nigeria.

Articles citing this

Hypertension in pediatric patients with chronic kidney disease: management challenges. Int J Nephrol Renovasc Dis (2017) 0.75

Articles cited by this

(truncated to the top 100)

The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics (2004) 31.85

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2009) 12.66

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int (2002) 9.29

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med (2004) 6.52

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant (2003) 6.15

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med (2003) 5.47

Underdiagnosis of hypertension in children and adolescents. JAMA (2007) 5.41

Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA (2007) 5.31

Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr (2007) 4.63

Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol (2007) 4.59

A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis (2008) 3.93

Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens (1988) 3.86

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int (2005) 3.71

Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Lancet (1997) 2.88

Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension (2008) 2.84

Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics (2003) 2.49

The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int (2007) 2.40

Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int (2003) 2.40

Pathophysiology of vascular calcification in chronic kidney disease. Circ Res (2004) 2.16

Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int (2007) 2.15

Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int (2009) 2.10

Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int (2009) 2.09

The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol (1992) 2.03

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Am J Kidney Dis (2008) 2.02

Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int (2008) 2.00

The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics (2004) 1.87

Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int (2012) 1.82

Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism. Nephrol Dial Transplant (2008) 1.81

Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol (2009) 1.80

Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. Am J Pathol (2006) 1.75

KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis (2009) 1.72

Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant (2005) 1.71

Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J (1993) 1.58

Phosphorus balance and mineral metabolism with 3 h daily hemodialysis. Kidney Int (2006) 1.51

Prevalence of complications in children with chronic kidney disease according to KDOQI. Kidney Int (2006) 1.51

Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. J Am Soc Nephrol (2005) 1.50

Control of hypertension in children after renal transplantation. Pediatr Transplant (2006) 1.47

Mechanical principles in arterial disease. Hypertension (1995) 1.43

Inhibition by pyrophosphate and polyphosphate of aortic calcification induced by vitamin D3 in rats. Clin Sci (1968) 1.43

A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant (2004) 1.42

FGF23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol (2010) 1.42

Leptin and renal disease. Am J Kidney Dis (2002) 1.42

Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol (2001) 1.38

Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int (1995) 1.38

Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA). Clin J Am Soc Nephrol (2009) 1.37

Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol (2005) 1.37

Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation (2003) 1.36

Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol (2008) 1.35

Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4. Am J Kidney Dis (2004) 1.31

Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics (2003) 1.30

Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol (2007) 1.27

Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis (2005) 1.25

Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int (1996) 1.24

Kidney in hypertension: guyton redux. Hypertension (2008) 1.23

Phosphate binder impact on bone remodeling and coronary calcification--results from the BRiC study. Nephron Clin Pract (2008) 1.22

Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol (2006) 1.21

The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am J Physiol Renal Physiol (2004) 1.20

Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy. Data from the Ital Kid Project. Pediatr Nephrol (2003) 1.15

A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate. Curr Med Res Opin (2007) 1.15

Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema. Am J Cardiol (2002) 1.12

Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol (2001) 1.11

The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiol (2003) 1.09

Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol (2000) 1.08

Mechanism of erythropoietin-induced hypertension. Am J Kidney Dis (1999) 1.08

Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension. Am J Hypertens (1998) 1.08

Posttransplantation hypertension related to calcineurin inhibitors. Liver Transpl (2000) 1.02

Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. J Am Soc Nephrol (2005) 1.00

Chronic renal failure in children: a report from Port Harcourt, Nigeria (1985-2000). Pediatr Nephrol (2003) 0.99

The spectrum of chronic renal failure among Jordanian children. J Nephrol (2002) 0.99

Left ventricular mass in normotensive, prehypertensive and hypertensive children and adolescents. Pediatr Nephrol (2009) 0.98

A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Musculoskelet Neuronal Interact (2007) 0.98

Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease. Pediatr Nephrol (2008) 0.97

Hypertension in children with chronic kidney disease: pathophysiology and management. Pediatr Nephrol (2007) 0.97

Nitric oxide and blood pressure: effects of nitric oxide deficiency. Curr Opin Nephrol Hypertens (1996) 0.95

Klotho and kidney disease. J Nephrol (2010) 0.95

Impaired endothelium-dependent vasodilatation in uraemia. Nephrol Dial Transplant (2000) 0.94

Cinacalcet is efficacious in pediatric dialysis patients. Pediatr Nephrol (2008) 0.94

Office and ambulatory blood pressure elevation in children with chronic renal failure. Pediatr Nephrol (2002) 0.94

Enhancement by locally generated angiotensin II of release of the adrenergic transmitter in the isolated rat kidney. J Pharmacol Exp Ther (1983) 0.92

Efficacy and safety of lanthanum carbonate on chronic kidney disease-mineral and bone disorder in dialysis patients: a systematic review. BMC Nephrol (2013) 0.91

Hypertension in dialysed children: the prevalence and therapeutic approach in Poland--a nationwide survey. Nephrol Dial Transplant (2005) 0.91

Chronic renal failure in children: an epidemiological survey in Lorraine (France) 1975-1990. Pediatr Nephrol (1994) 0.91

The renin-aldosterone axis in two models of reduced renal mass in the rat. J Am Soc Nephrol (1998) 0.90

Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther (2006) 0.90

New strategies for the treatment of hyperparathyroidism incorporating calcimimetics. Expert Opin Pharmacother (2008) 0.90

Use of calcium-channel blockers in pediatric renal transplant recipients. Pediatr Transplant (1999) 0.89

Middle-term use of Cinacalcet in paediatric dialysis patients. Pediatr Nephrol (2009) 0.89

Parathyroid hormone and growth in children with chronic renal failure. Kidney Int (2005) 0.89

Blood pressure control in pediatric hemodialysis: the Midwest Pediatric Nephrology Consortium Study. Pediatr Nephrol (2006) 0.89

Growth in children with chronic renal failure on intermittent versus daily calcitriol. Pediatr Nephrol (2003) 0.86

Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication. World J Nephrol (2012) 0.86

Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease. Pediatr Nephrol (2006) 0.85

The fibroblast growth factor 23: a new player in the field of cardiovascular, bone and renal disease. Curr Vasc Pharmacol (2010) 0.85

Effect of blocking angiotensin II receptor subtype on rat sympathetic nerve function. Hypertension (1992) 0.84

Twenty-four-hour ambulatory blood pressure profiles in pediatric patients after renal transplantation. Pediatr Nephrol (1997) 0.82

Endothelin-1 in chronic renal failure and hypertension. Can J Physiol Pharmacol (2003) 0.82

Determinants of the intima-media thickness in children and adolescents with chronic kidney disease. Pediatr Nephrol (2008) 0.81

Enalapril attenuates endothelin-1-induced hypertension via increased kinin survival. Am J Physiol Heart Circ Physiol (2003) 0.80

Hypertension secondary to early-stage kidney disease: the pathogenetic role of altered cytosolic calcium (Ca2+) homeostasis of vascular smooth muscle cells. Am J Kidney Dis (1993) 0.79

Effects of hypercalcemia and parathyroid hormone on blood pressure in normal and renal-failure rats. Am J Physiol (1986) 0.79